{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T02:25:49Z","timestamp":1794623149364,"version":"4.9.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.nano.2026.103043","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:14:11Z","timestamp":1792538051000},"page":"103043","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Model-dependent transport limitations shape the in vitro evaluation of platinum-based nanotherapeutics"],"prefix":"10.1016","volume":"78","author":[{"given":"Chiara","family":"Vitale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elisabetta F.","family":"Palam\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Fedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Iafisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Barbanente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Margiotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo Degli","family":"Esposti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Castriconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Aiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Scaglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.nano.2026.103043_bb0005","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.7150\/thno.69424","article-title":"Platinum-based drugs for cancer therapy and anti-tumor strategies","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics"},{"issue":"8","key":"10.1016\/j.nano.2026.103043_bb0010","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc2167","article-title":"The resurgence of platinum-based cancer chemotherapy","volume":"7","author":"Kelland","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"10.1016\/j.nano.2026.103043_bb0015","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nnano.2007.387","article-title":"Nanocarriers as an emerging platform for cancer therapy","volume":"2","author":"Peer","year":"2007","journal-title":"Nat Nanotechnol"},{"issue":"24","key":"10.1016\/j.nano.2026.103043_bb0020","doi-asserted-by":"crossref","first-page":"16512","DOI":"10.1039\/D3RA01476B","article-title":"Hydroxyapatite-based carriers for tumor targeting therapy","volume":"13","author":"Qian","year":"2023","journal-title":"RSC Adv"},{"issue":"39","key":"10.1016\/j.nano.2026.103043_bb0025","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.2174\/0113816128368718250320060346","article-title":"Nanoparticles as novel drug delivery systems for cancer treatment: current status and future perspectives","volume":"31","author":"Bin","year":"2025","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.nano.2026.103043_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2020.111334","article-title":"Selenium-doped hydroxyapatite nanoparticles for potential application in bone tumor therapy","volume":"215","author":"Barbanente","year":"2021","journal-title":"J Inorg Biochem"},{"issue":"14","key":"10.1016\/j.nano.2026.103043_bb0035","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1039\/D0TB00390E","article-title":"Platinum-loaded, selenium-doped hydroxyapatite nanoparticles selectively reduce proliferation of prostate and breast cancer cells co-cultured in the presence of stem cells","volume":"8","author":"Barbanente","year":"2020","journal-title":"J Mater Chem B"},{"issue":"44","key":"10.1016\/j.nano.2026.103043_bb0040","doi-asserted-by":"crossref","first-page":"8385","DOI":"10.1039\/b914379c","article-title":"Smart delivery of antitumoral platinum complexes from biomimetic hydroxyapatite nanocrystals","volume":"19","author":"Iafisco","year":"2009","journal-title":"J Mater Chem"},{"issue":"1","key":"10.1016\/j.nano.2026.103043_bb0045","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1039\/C1NR11147G","article-title":"Nanocrystalline carbonate-apatites: role of Ca\/P ratio on the upload and release of anticancer platinum bisphosphonates","volume":"4","author":"Iafisco","year":"2011","journal-title":"Nanoscale"},{"key":"10.1016\/j.nano.2026.103043_bb0050","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jinorgbio.2012.06.013","article-title":"What do we know about the reduction of Pt(IV) pro-drugs?","volume":"117","author":"Wexselblatt","year":"2012","journal-title":"J Inorg Biochem"},{"issue":"S4","key":"10.1016\/j.nano.2026.103043_bb0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1634\/theoncologist.9-90004-3","article-title":"Bisphosphonates: preclinical review","volume":"9","author":"Green","year":"2004","journal-title":"Oncologist"},{"issue":"12","key":"10.1016\/j.nano.2026.103043_bb0060","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1158\/0008-5472.CAN-05-0264","article-title":"Bisphosphonates and cancer-induced bone disease: beyond their antiresorptive activity","volume":"65","author":"Cl\u00e9zardin","year":"2005","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.nano.2026.103043_bb0065","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1021\/ic00226a004","article-title":"Multinuclear NMR study of reactions of methylphosphonic acid, CH3PO3H2, and (Aminoalkyl)phosphonic acids, NH2(CH2)nPO3H2 (n = 1\u20133), with the cis-Diamminediaquaplatinum(II) Cation and cis-Diamminedihydroxoplatinum(II)","volume":"25","author":"Appleton","year":"1986","journal-title":"Inorg Chem"},{"issue":"6","key":"10.1016\/j.nano.2026.103043_bb0070","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1021\/ic00226a005","article-title":"NMR spectra of Iminobis(methylenephosphonic acid), HN(CH2PO3H2)2, and related ligands and of their complexes with platinum(II)","volume":"25","author":"Appleton","year":"1986","journal-title":"Inorg Chem"},{"issue":"AUG","key":"10.1016\/j.nano.2026.103043_bb0075","article-title":"Cell-laden hydrogel as a clinical-relevant 3D model for analyzing neuroblastoma growth, immunophenotype, and susceptibility to therapies","volume":"10","author":"Marrella","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.nano.2026.103043_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245536","article-title":"High blood flow shear stress values are associated with circulating tumor cells cluster disaggregation in a multi-channel microfluidic device","volume":"16","author":"Marrella","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2026.103043_bb0085","article-title":"Nanoparticle accumulation and penetration in 3D tumor models: the effect of size, shape, and surface charge","volume":"12","author":"Cybulski","year":"2024","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"10.1016\/j.nano.2026.103043_bb0090","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1039\/D3NH00305A","article-title":"Advances in screening hyperthermic nanomedicines in 3D tumor models","volume":"9","author":"Soeiro","year":"2024","journal-title":"Nanoscale Horiz"},{"issue":"35","key":"10.1016\/j.nano.2026.103043_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202402311","article-title":"Tumor-on-a-chip models for predicting in vivo nanoparticle behavior","volume":"20","author":"de Roode","year":"2024","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.nano.2026.103043_bb0100","first-page":"82","article-title":"3D fluid-dynamic ovarian cancer model resembling systemic drug administration for efficacy assay","volume":"38","author":"Marrella","year":"2021","journal-title":"ALTEX"},{"issue":"16","key":"10.1016\/j.nano.2026.103043_bb0105","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1021\/jm3006838","article-title":"Revisiting [PtCl2(cis-1,4-DACH)]: an underestimated antitumor drug with potential application to the treatment of oxaliplatin-refractory colorectal cancer","volume":"55","author":"Margiotta","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.nano.2026.103043_bb0110","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1039\/b705239a","article-title":"Bisphosphonate complexation and calcium doping in silica xerogels as a combined strategy for local and controlled release of active platinum antitumor compounds","volume":"29","author":"Margiotta","year":"2007","journal-title":"Dalton Trans"},{"issue":"13","key":"10.1016\/j.nano.2026.103043_bb0115","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1002\/adfm.200600361","article-title":"Biomimetic hydroxyapatite\u2013drug nanocrystals as potential bone substitutes with antitumor drug delivery properties","volume":"17","author":"Palazzo","year":"2007","journal-title":"Adv Funct Mater"},{"issue":"13","key":"10.1016\/j.nano.2026.103043_bb0120","doi-asserted-by":"crossref","first-page":"7482","DOI":"10.1021\/acs.inorgchem.7b00931","article-title":"Novel kiteplatin pyrophosphate derivatives with improved efficacy","volume":"56","author":"Curci","year":"2017","journal-title":"Inorg Chem"},{"issue":"13","key":"10.1016\/j.nano.2026.103043_bb0125","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1002\/adfm.200600361","article-title":"Biomimetic hydroxyapatite\u2013drug nanocrystals as potential bone substitutes with antitumor drug delivery properties","volume":"17","author":"Palazzo","year":"2007","journal-title":"Adv Funct Mater"},{"issue":"25","key":"10.1016\/j.nano.2026.103043_bb0130","doi-asserted-by":"crossref","first-page":"13582","DOI":"10.1039\/D0NR04064A","article-title":"Preclinical evaluation of platinum-loaded hydroxyapatite nanoparticles in an embryonic zebrafish xenograft model","volume":"12","author":"Nadar","year":"2020","journal-title":"Nanoscale"},{"issue":"2","key":"10.1016\/j.nano.2026.103043_bb0135","article-title":"A human ovarian tumor & liver organ-on-chip for simultaneous and more predictive toxo-efficacy assays","volume":"10","author":"Fedi","year":"2023","journal-title":"Bioengineering (Basel)"},{"issue":"4","key":"10.1016\/j.nano.2026.103043_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14041013","article-title":"Tumor microenvironment and hydrogel-based 3D cancer models for in vitro testing immunotherapies","volume":"14","author":"Vitale","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"19","key":"10.1016\/j.nano.2026.103043_bb0145","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1016\/j.biomaterials.2007.02.028","article-title":"Micro-Raman and FTIR studies of synthetic and natural apatites","volume":"28","author":"Antonakos","year":"2007","journal-title":"Biomaterials"},{"issue":"11","key":"10.1016\/j.nano.2026.103043_bb0150","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.1021\/jp510492m","article-title":"A Step toward control of the surface structure of biomimetic hydroxyapatite nanoparticles: effect of carboxylates on the {010} P-Rich\/Ca-rich facets ratio","volume":"119","author":"Sakhno","year":"2015","journal-title":"J Phys Chem C"},{"issue":"4","key":"10.1016\/j.nano.2026.103043_bb0155","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1007\/s12598-024-03058-0","article-title":"Design of a theranostic Gd (III)\u2013Cu (I) complex to inhibit growth and metastasis of triple-negative breast cancer","volume":"44","author":"Man","year":"2025","journal-title":"Rare Metals"},{"issue":"12","key":"10.1016\/j.nano.2026.103043_bb0160","doi-asserted-by":"crossref","first-page":"13113","DOI":"10.1021\/acs.jmedchem.5c01235","article-title":"Development of a high-efficacy and low-toxicity cobalt(II) agent for targeting inhibition of tumor growth through mitochondrial damage-mediated chemotherapy and immunotherapy","volume":"68","author":"Zhu","year":"2025","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.nano.2026.103043_bb0165","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1021\/acs.jmedchem.5c01882","article-title":"Developing a vanadium(IV) complex for targeted inhibition of growth and metastasis of tumors by multiacting on Cancer cells and dual activating immune system","volume":"69","author":"Gao","year":"2026","journal-title":"J Med Chem"},{"issue":"10","key":"10.1016\/j.nano.2026.103043_bb0170","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.3390\/pharmaceutics13101642","article-title":"Hydroxyapatite nanoparticles in drug delivery: physicochemistry and applications","volume":"13","author":"Lara-Ochoa","year":"2021","journal-title":"Pharmaceutics"},{"issue":"JUL","key":"10.1016\/j.nano.2026.103043_bb0175","article-title":"Current trends and challenges in the clinical translation of nanoparticulate nanomedicines: pathways for translational development and commercialization","volume":"9","author":"Hua","year":"2018","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.nano.2026.103043_bb0180","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.1038\/s41598-018-23250-4","article-title":"A new cell-laden 3D alginate-matrigel hydrogel resembles human breast cancer cell malignant morphology, spread and invasion capability observed \u201cin vivo\u201d","volume":"8","author":"Cavo","year":"2018","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.nano.2026.103043_bb0185","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1039\/C4DT01796J","article-title":"DNA fragment conformations in adducts with Kiteplatin","volume":"44","author":"Margiotta","year":"2015","journal-title":"Dalton Trans"},{"key":"10.1016\/j.nano.2026.103043_bb0190","article-title":"Targeted therapeutic strategies for triple-negative breast cancer","volume":"11","author":"Li","year":"2021","journal-title":"Front Oncol"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426001449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426001449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:41:30Z","timestamp":1794620490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963426001449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":38,"alternative-id":["S1549963426001449"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2026.103043","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Model-dependent transport limitations shape the in vitro evaluation of platinum-based nanotherapeutics","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2026.103043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103043"}}